Expertise in
2
conditions

Teresa C. Bonfill

Sabadell, CT, ES 
Expertise in
2
conditions
Sabadell, CT, ES 

Overview

Teresa Bonfill practices practicing medicine in Sabadell, Spain.

Ms. Bonfill is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Silent Thyroiditis, Bladder Cancer, Prostate Cancer, and Cystectomy.

She is actively involved in clinical research, co-authoring 20 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Sabadell, CT, Spain
Other Locations
Caceres, EX, Spain
Barcelona, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
Enrollment Status: Terminated
Publish Date: September 08, 2025
Intervention Type: Drug
Study Drugs: Trilaciclib, Gemcitabine, Cisplatin, Carboplatin, Avelumab
Study Phase: Phase 2
Phase II Multicentre, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Avelumab With Gemcitabine/Carboplatin Versus Gemcitabine/Carboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma (UC) Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.
Phase II Multicentre, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Avelumab With Gemcitabine/Carboplatin Versus Gemcitabine/Carboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma (UC) Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.
Enrollment Status: Completed
Publish Date: October 18, 2023
Intervention Type: Combination product
Study Drugs: Avelumab 10mg/kg with Carboplatin/Gemcitabine, Carboplatin/Gemcitabine Alone
Study Phase: Phase 2
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer (Study ATEZOBLADDERPRESERVE)
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer (Study ATEZOBLADDERPRESERVE)
Enrollment Status: Active_not_recruiting
Publish Date: October 26, 2022
Intervention Type: Radiation, Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
View 2 Less Clinical Trials

20 Total Publications

Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients.
Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients.
Journal: Oncoimmunology
Published: August 08, 2025

Frequently Asked Questions about Teresa C. Bonfill

Is Teresa C. Bonfill a top-rated expert for Urothelial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Teresa C. Bonfill is classified as an Advanced expert for Urothelial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Teresa C. Bonfill participate in research or clinical trials?

Yes. Teresa C. Bonfill has published 20 articles and abstracts on conditions like Urothelial Cancer. You can view a list of Teresa C. Bonfill's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bonfill's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile